KIRs and autoimmune disease: Studies in systemic lupus erythematosus and scleroderma

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 106-108

  Pellett, F ^a   Siannis, F ^b   Vukin, I ^a   Lee, P ^c   Urowitz, M B ^c   Gladman, D D ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE ANTIGEN;

AUTOIMMUNE DISEASE; CAUCASIAN; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; INHIBITION KINETICS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

CADAVER; CASE-CONTROL STUDIES; GENOTYPE; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; SCLERODERMA, DIFFUSE; TISSUE DONORS;

EID: 34247271523     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.762_6.x     Document Type: Conference Paper

References (5)

1. Yen JH, Moore BE, Nakajima T et al. Major histocompatibility complex Class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001: 193: 1159-67.
2. Van der Slik AR, Koeleman BPC, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003: 52: 2639-42.
3. Momot T, Koch S, Hunzelmann N et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004: 50: 1561-5.
4. Nakajima T, Goek O, Zhang X et al. De Novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 2003: 93: 106-13.
5. Martin MP, Nelson G, Lee JH et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002: 169: 2818-22.